CFO Oversees Quarters Sales Growth, Drives AI Strategy
CFO Mandy Fields shifts to lead e.l.f. Beauty's AI strategy, anchoring governance, commerce readiness and efficiency ...
Using Credit Card Rewards For Everyday Expenses
Using credit card rewards for everyday expenses can help you save money. Discover strategies to make your rewards work harder for you.
16,598 articlesWill Verisk's Valuable Data Survive AI Commoditization?
As AI accelerates, the question for investors is clear: will Verisk's valuable data keep its edge or fade into a sea ...
These Words From Lilly's CEO Signal Bullish Wall Street
A single conference-call moment changed the mood around Eli Lilly. By unpacking eight key themes from the CEO, invest...
Texas Instruments Smashing NVIDIA in 2026: Market Shakeup
Texas Instruments is outperforming NVIDIA in 2026 as the chip landscape shifts from GPU hype to broad AI infrastructu...
Maxed TSMC, Samsung Hynix: EM Funds Hunt New Bets Today
Funds that rode big EM winners are rotating out of maxed TSMC and Samsung Hynix and chasing new catalysts. The shift ...
Three Value ETFs Beat Market in 2026 with Distinct Playbooks
Three value-focused ETFs outperformed the broad market in 2026, each using a different approach to value. AVLV, AVUV,...
Trump Issues Pardon Former Republican Congressman 2026
A former Republican congressman receives a presidential pardon from Trump, erasing insider-trading gains tied to a ma...
SOXQ Semiconductor Surges 181.74% as AI Chip Boom Rises Global
SOXQ has surged 181.74% in the past year as AI chip demand powers gains across NVIDIA, Broadcom, and AMD, while the E...
Elon Musk Reveals Insane Plan to Double Chip Output
Elon Musk has floated a colossal Terafab project aimed at dramatically scaling U.S. chip production from a single pla...
Super Micro Computer vs Dell: Which Stock Leads 2026 AI Push
Dell Technologies beat on revenue with a strong AI server push, while Super Micro Computer posted healthy growth that...
Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status